Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carmen Navarrete‐Sirvent
Observed names:
Carmen Navarrete Sirvent,
Carmen Navarrete-Sirvent,
Navarrete-Sirvent, Carmen
Institutions:
Instituto Maimónides de Investigación Biomédica de Córdoba,
Centro de Investigación Biomédica en Red de Cáncer
Observed institutions:
Instituto Maimónides de Investigación Biomédica de Córdoba,
Hospital Universitario Reina Sofía,
Roche (Spain),
Centro de Investigación Biomédica en Red de Cáncer,
University of Córdoba
ORCID:
0000-0002-8839-335X
Observed ORCID:
0000-0002-8839-335X
OpenAlex ID:
A5086833466
Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived Xenografts
2020
·
Silvia Guil-Luna
, Rafael Mena
, et al.
·
Frontiers in Medicine
·
23
PDF
Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy
2023
·
Silvia Guil-Luna
, Aurora Rivas-Crespo
, et al.
·
Biomedicine & Pharmacotherapy
·
19
Metabolic shift underlies tumor progression and immune evasion in S‐nitrosoglutathione reductase‐deficient cancer
2023
·
Rafael Mena‐Osuna
, Ana Mantrana
, et al.
·
The Journal of Pathology
·
8
Glycolysis Inhibition Restores Immune Sensitivity in GSNOR–Deficient Colorectal Cancer
2025
·
Ana Mantrana
, María Teresa Sánchez-Montero
, et al.
·
Laboratory Investigation
·
3
Imbalanced NK cell subpopulations and TIGIT expression limit cetuximab efficacy in colorectal cancer: A promising target for treatment enhancement
2025
·
Carmen Navarrete‐Sirvent
, Ana Mantrana
, et al.
·
Clinical and Translational Medicine
·
3
PDF
Proteomic and immunophenotypic signatures reveal immune-mediated resistance to cetuximab in metastatic colorectal cancer
2026
·
Carmen Navarrete Sirvent
, Aurora Rivas-Crespo
, et al.
PDF
Establishment of humanized patient-derived xenografts (PDXs) from primary human colorectal cancer tumors
2026
·
Carmen Navarrete-Sirvent
, Aurora Rivas-Crespo
, et al.
·
Methods in cell biology
Las células NK como biomarcadores de respuesta a la terapia anti-EGFR en cáncer colorrectal metastásico: implicaciones clínicas y oportunidades terapéuticas
2026
·
Navarrete-Sirvent, Carmen
·
Universidad de Córdoba Insitutional Repository (Universidad de Córdoba)
Show more works
View as search
Works count:
8
Citation count:
56
H-index:
3
I10-index:
2
Year
Topic
Type